Skip to main content
Log in

Differential effects of sodium bicarbonate and aluminium hydroxide on the absorption and activity of glipizide

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effects of sodium bicarbonate and aluminium hydroxide on the absorption and activity of glipizide have been studied in healthy volunteers in two randomized cross-over trials. After an overnight fast, 5 mg glipizide was given either with 150 ml water or with water containing 3.0 g sodium bicarbonate or 1.0 g aluminium hydroxide.

Sodium bicarbonate significantly increased the AUC of plasma glipizide from 0 to 0.5 h, 0 to 1 h, and from 0 to 2 h (six-, four- and twofold, respectively). The time to peak concentration (tmax) fell from 2.5 h during the control phase to 1.0 h during the sodium bicarbonate phase. The absorption half-life (t1/2a), lag time and mean residence time (MRT) were also significantly decreased. No significant change in peak plasma concentration (Cmax), total AUC or elimination half-life (t1/2) was noted. The decremental plasma glucose areas from 0 to 1 h and 0 to 2 h were significantly larger (80% and 50%, respectively) than during the control phase. The maximal decrease in glucose was 50% greater during the sodium bicarbonate phase, and the time to reach it was reduced by 35 min. Aluminium hydroxide had no significant effects on the rate or extent of absorption of glipizide, and the glucose response also remained unaffected.

It is concluded that the concomitant ingestion of sodium bicarbonate and glipizide may result in accelerated absorption of glipizide and an increased effect on glucose. A common dose of aluminium hydroxide did not appear to affect the absorption of glipizide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wåhlin-Boll E, Almer L-O, Melander A (1982) Bioavailability, pharmacokinetics and effects of glipizide in type 2 diabetics. Clin Pharmacokinet 7: 363–372

    Google Scholar 

  2. Kradjan WA, Kobayashi KA, Bauer LA, Horn JR, Opheim KE, Wood FJ (1989) Glipizide pharmacokinetics: effects of age, diabetes, and multiple dosing. J Clin Pharmacol 29: 1121–1127

    Google Scholar 

  3. Hartling SG, Faber OK, Wegmann M-L, Wåhlin-Boll E, Melander A (1987) Interaction of ethanol and glipizide in humans. Diabetes Care 10: 683–686

    Google Scholar 

  4. Ikegami H, Shima K, Tanaka A, Tahara Y, Hirota M, Kumahara Y (1986) Interindividual variation in the absorption of glibenclamide in man. Acta Endocrinol 111: 528–532

    Google Scholar 

  5. Melander A, Bitzen P-O, Faber O, Groop L (1989) Sulphonylurea antidiabetic drugs: an update of their clinical pharmacology and rational therapeutic use. Drugs 37: 58–72

    Google Scholar 

  6. Wåhlin-Boll E, Melander A, Sartor G, Schersten B (1980) Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects. Eur J Clin Pharmacol 18: 279–283

    Google Scholar 

  7. Hurwitz A (1977) Antacid therapy and drug kinetics. Clin Pharmacokinet 2: 269–280

    Google Scholar 

  8. Gugler R, Allgayer H (1990) Effects of antacids on the clinical pharmacokinetics of drugs: an update. Clin Pharmacokinet 18: 210–219

    Google Scholar 

  9. Neuvonen PJ, Kivistö KT (1988) Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids. Eur J Clin Pharmacol 35: 495–501

    Google Scholar 

  10. Segre EJ, Sevelius H, Varady J (1974) Effects of antacids on naproxen absorption. N Engl J Med 291: 582–583

    Google Scholar 

  11. Hurwitz A, Schlozman DL (1974) Effects of antacids on gastrointestinal absorption of isoniazid in rat and man. Am Rev Respir Dis 109: 41–47

    Google Scholar 

  12. Verbeeck R, Tjandramaga TB, Mullie A, Verbesselt R, DeSchepper PJ (1979) Effect of aluminium hydroxide on diflunisal absorption. Br J Clin Pharmacol 7: 519–522

    Google Scholar 

  13. Wåhlin-Boll E, Melander A (1979) High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum. J Chromatogr 164: 541–546

    Google Scholar 

  14. Emilsson H (1987) High-performance liquid chromatographic determination of glipizide in human plasma and urine. J Chromatogr 421: 319–326

    Google Scholar 

  15. Tuderman V, Klinge E, Lind H (1982) In vitro evaluations of antacid suspensions marketed in Finland. Acta Pharm Fenn 91: 153–173

    Google Scholar 

  16. Marchetti P, Navalesi R (1989) Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents: an update. Clin Pharmacokinet 16: 100–128

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kivistö, K.T., Neuvonen, P.J. Differential effects of sodium bicarbonate and aluminium hydroxide on the absorption and activity of glipizide. Eur J Clin Pharmacol 40, 383–386 (1991). https://doi.org/10.1007/BF00265848

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00265848

Key words

Navigation